Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Hui Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3972-1297; OpenAlex author ID A5100742769. Sources: OpenAlex.

Their work

Papers
24 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
61
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 7 papers · 2022: 5 papers · 2023: 3 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 24

  1. Anatomy-informed CT Spatial Phenotype Associated with Extrapancreatic Perineural Invasion in Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1148/ryai.260357↗
  2. Large-scale pancreatic cancer detection via non-contrast CT and deep learning. Co-author DOI 10.1038/s41591-023-02640-w↗
  3. Artificial Intelligence to Predict Lymph Node Metastasis at CT in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1148/radiol.220329↗
  4. A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-023-11181-x↗
  5. Contrast-enhanced computed tomography radiomics and multilayer perceptron network classifier: an approach for predicting CD20+ B cells in patients with pancrea… Co-author DOI 10.1007/s00261-021-03285-4↗
  6. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-022-03512-6↗
  7. CT Radiomics Features in Differentiation of Focal-Type Autoimmune Pancreatitis from Pancreatic Ductal Adenocarcinoma: A Propensity Score Analysis. Co-author DOI 10.1016/j.acra.2021.04.014↗
  8. Prediction of Tumor-Infiltrating CD20+ B-Cells in Patients with Pancreatic Ductal Adenocarcinoma Using a Multilayer Perceptron Network Classifier Based on Non-… Co-author DOI 10.1016/j.acra.2021.11.013↗
  9. Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40644-021-00443-1↗
  10. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in P… Co-author DOI 10.1002/jmri.27648↗
  11. Machine learning for MRI radiomics: a study predicting tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-021-03159-9↗
  12. The relationship between microscopic tumor size and CT tumor size in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.clinimag.2020.11.039↗
  13. Downregulation of GSTM2 enhances gemcitabine chemosensitivity of pancreatic cancer in vitro and in vivo. Co-author DOI 10.1016/j.pan.2020.12.008↗
  14. XGBoost Classifier Based on Computed Tomography Radiomics for Prediction of Tumor-Infiltrating CD8+ T-Cells in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.671333↗
  15. Tumor Budding Score Is a Strong and Independent Prognostic Factor in Patients With Pancreatic Ductal Adenocarcinoma: An Evaluation of Whole Slide Pathology Ima… Co-author DOI 10.3389/fonc.2021.740212↗
  16. B3GNT3: A prognostic biomarker associated with immune cell infiltration in pancreatic adenocarcinoma. Co-author DOI 10.3892/ol.2020.12420↗
  17. Pros and Cons: High Proportion of Stromal Component Indicates Better Prognosis in Patients With Pancreatic Ductal Adenocarcinoma-A Research Based on the Evalua… Co-author DOI 10.3389/fonc.2020.01472↗
  18. Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001404↗
  19. Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: stu… Co-author DOI 10.1186/s13014-019-1254-8↗
  20. miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1. Co-author DOI 10.1159/000495328↗
  21. Association between vitamin A, retinol and carotenoid intake and pancreatic cancer risk: Evidence from epidemiologic studies. Co-author DOI 10.1038/srep38936↗
  22. LncRNAs in pancreatic cancer. Co-author DOI 10.18632/oncotarget.10545↗
  23. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. Co-author DOI 10.1007/s12032-015-0633-8↗
  24. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer. Co-author DOI 10.1245/s10434-011-1968-9↗

Closest collaborators

The 25 strongest of 61 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yun Bian · 14 shared papers, 2019–2026 · strength 1.88
  2. Chengwei Shao · 11 shared papers, 2021–2026 · strength 1.56
  3. Jieyu Yu · 9 shared papers, 2021–2026 · strength 1.28
  4. Jianping Lu · 9 shared papers, 2021–2023 · strength 1.11
  5. Kai Cao · 9 shared papers, 2019–2023 · strength 1.03
  6. Yinghao Meng · 7 shared papers, 2021–2022 · strength 0.85
  7. Li Wang · 7 shared papers, 2019–2022 · strength 0.81
  8. Jianping Lu · 5 shared papers, 2019–2026 · strength 0.79
  9. Jianming Zheng · 6 shared papers, 2016–2022 · strength 0.59
  10. Suizhi Gao · 5 shared papers, 2019–2023 · strength 0.58
  11. Gang Jin · 6 shared papers, 2012–2023 · strength 0.57
  12. Chao Ma · 4 shared papers, 2021–2022 · strength 0.52
  13. Shiwei Guo · 4 shared papers, 2019–2023 · strength 0.50
  14. Xiaohan Shi · 3 shared papers, 2019–2023 · strength 0.36
  15. Jing Li · 3 shared papers, 2021–2022 · strength 0.34
  16. Jianming Zheng · 3 shared papers, 2012–2021 · strength 0.33
  17. Ling Zhang · 2 shared papers, 2023 · strength 0.28
  18. Chengwei Chen · 1 shared paper, 2026 · strength 0.26
  19. Qi Li · 2 shared papers, 2021–2022 · strength 0.24
  20. Xiaoyi Huang · 3 shared papers, 2016–2018 · strength 0.22
  21. Na Ta · 3 shared papers, 2016–2018 · strength 0.22
  22. Lingyu Zhu · 1 shared paper, 2023 · strength 0.16
  23. Gang Y Jin · 1 shared paper, 2023 · strength 0.16
  24. Shuo Shen · 1 shared paper, 2023 · strength 0.16
  25. Jian Wang · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.